SEC v. TEVA PHARMACEUTICALS USA, No. 1:23-cv-01491, Southern District of New York (Jan. 30, 2026) — Judgment
raw: Stipulation And Order Of Settlement
Stipulation And Order Of Settlement, No. 1:23-cv-01491 (Jan. 30, 2026)
Classified non-corporate(confidence 95%). No EDGAR filing fingerprint (criminal/DOJ-side scheme). detection rule →
Statutes
15 U.S.C. § 78j(b)
Parties
WintersTeva Pharmaceuticals USA, Inc.
Keywords
document pagecv-jgkdocumentpage
Extracted insights
Triples 2
- Case 1:23-Cv-01491-JGK Filed 01/26/26
- Case 1:23-Cv-01491-JGK Includes Document 73
Text layers
Extracted body text (381c)
Case 1:23-cv-01491-JGK Document 73 Filed 01/26/26 Page 1 of 5 Case 1:23-cv-01491-JGK Document 73 Filed 01/26/26 Page 2 of 5 Case 1:23-cv-01491-JGK Document 73 Filed 01/26/26 Page 3 of 5 Case 1:23-cv-01491-JGK Document 73 Filed 01/26/26 Page 4 of 5 Case 1:23-cv-01491-JGK Document 73 Filed 01/26/26 Page 5 of 5
OCR text (381c · textlayer+stamponly · 86% conf)
Case 1:23-cv-01491-JGK Document 73 Filed 01/26/26 Page 1 of 5 Case 1:23-cv-01491-JGK Document 73 Filed 01/26/26 Page 2 of 5 Case 1:23-cv-01491-JGK Document 73 Filed 01/26/26 Page 3 of 5 Case 1:23-cv-01491-JGK Document 73 Filed 01/26/26 Page 4 of 5 Case 1:23-cv-01491-JGK Document 73 Filed 01/26/26 Page 5 of 5